Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
General Introduction | China National Nuclear Power Technology Development Co., Ltd. (stock abbreviation: China National Nuclear Power Technology, stock code: 000881. SZ) is a "6+1" industrial system non power nuclear technology application industry development platform of China National Nuclear Power Corporation (referred to as "China National Nuclear Power Corporation"), a leading enterprise in China's non power nuclear technology application industry, and the first stock in China's non power nuclear technology application industry. It strives to develop into a new pillar industry of China National Nuclear Power Corporation and is moving towards becoming a world-class leader in the nuclear technology application industry. As a comprehensive reform enterprise under the "Double Hundred Actions" of the State owned Assets Supervision and Administration Commission of the State Council and the fourth batch of pilot enterprises under the "Mixed Ownership" reform of the National Development and Reform Commission, the company continues to explore new models of mixed ownership development, achieving the integrated development of state-owned capital and private capital. The company's mission is to "make nuclear technology better for human life", focusing on the nuclear technology application industry, guided by the A+strategy, and deepening and expanding around the four major business layouts. In terms of accelerator and irradiation business, the company holds a high market share in the manufacturing of industrial electron accelerators in China, with full coverage of high, medium, and low energy industrial electron accelerators, firmly ranking first in the domestic nuclear technology application team. At the same time, we are vigorously developing our nuclear environmental protection business, collaborating with Tsinghua University to develop a globally leading electron beam treatment technology for special waste, and actively expanding into the field of nuclear agriculture; In terms of new material business, the company is a leading manufacturer of polymer composite materials in China and also one of the main production enterprises of special cable materials in the country; In terms of entrusted management of measurement and control equipment business, the market size remains at the forefront of the country, with customs, border inspection, nuclear power, etc. as the main markets, and some products breaking foreign monopolies; In terms of medical and health business, the company has entered the high-end medical field of nuclear technology application, introduced global advanced proton therapy tumor technology, and is committed to achieving independent and controllable domestic high-end medical equipment. It has also laid out a project for the production of medical isotopes using the Zhongneng Cyclotron. 2022 is the "year of implementation" for nuclear technology companies. All cadres and employees maintain the "A+" strategic focus, adhere to the overall tone of "stability first, seeking progress while maintaining stability", deeply practice the "strict, cautious, and meticulous" work style, withstand severe internal and external challenges, achieve stable and improved business performance, and overall complete the "seven implementation" work deployment, accumulating strong momentum for promoting high-quality development. |
Headquarter | Dalian |
Establish Date | 4/17/1993 |
Listed Code | 000881.SZ |
Listed Date | 9/2/1998 |
Chairman | Li Yong. |
CEO | Sheng Guofu. |
Website | www.cgnnt.com.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial